by Jordana Choucair | Jul 7, 2022 | Life Sciences
The Food and Drug Administration (FDA) said state-licensed pharmacists can prescribe Pfizer Inc.’s COVID-19 antiviral pill Paxlovid to eligible patients. Pharmacists will be subject to some parameters around prescribing, and the FDA said people who test positive...
by Jordana Choucair | Jul 7, 2022 | Life Sciences
The FDA announced it will develop a new framework to help overseas baby formula manufacturers market their products in the U.S. after the formula shortage eases. The FDA would offer technical assistance to companies seeking to enter the U.S. market and issue...
by Jordana Choucair | Jul 7, 2022 | Payers
Senate Democrats will propose raising taxes on some high-income Americans to delay a shortfall in the Medicare trust fund. The fund is currently projected to start running out of money in 2028. The proposal would raise an estimated $203 billion over a decade and delay...
by Jordana Choucair | Jul 7, 2022 | Transition to Value
An analysis conducted by the Center for Medicare and Medicaid Innovation (CMMI) found issues with implicit bias within three major payment models: Kidney Care Choices, Comprehensive Care for Joint Replacement, and Million Hearts Cardiovascular Disease Risk Reduction....
by Jordana Choucair | Jul 6, 2022 | Life Sciences
The Food and Drug Administration (FDA) announced it has temporarily suspended its ban on sales of the e-cigarette maker Juul. The agency also said that the company is allowed to market its products in the U.S. for the time being. The announcement comes two weeks after...
Recent Comments